Biological correlates of diffusivity in brain abscess

Asht M Mishra1, Rakesh K Gupta, Sona Saksena

  • 1Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Insights

Viable cell density, not the cause of infection, is the primary factor limiting diffusion in brain abscesses. Diffusion-weighted imaging (DWI) reveals this key characteristic across different abscess types.

Area of Science:

  • Neuroimaging
  • Infectious Diseases
  • Biophysics

Background:

  • Restricted diffusion in brain abscesses is attributed to pus composition.
  • Previous studies linked diffusion changes to cell density in tumors.

Purpose of the Study:

  • To investigate the relationship between apparent diffusion coefficient (ADC) and pus characteristics in brain abscesses.
  • To determine the primary factor responsible for restricted diffusion in brain abscesses.

Main Methods:

  • Diffusion-weighted imaging (DWI) was performed on 41 patients with brain abscesses.
  • Apparent diffusion coefficient (ADC) values were correlated with quantified viable cell density, viscosity, and protein content of abscess pus.
  • Cell density was modeled within restricted and unrestricted lesion volumes.

Main Results:

  • A significant inverse correlation was found between restricted ADC and viable cell density in both pyogenic and tuberculous brain abscesses.
  • Mean restricted ADC was 0.65 ± 0.01 x 10⁻³ mm²/s for pyogenic and 0.60 ± 0.04 x 10⁻³ mm²/s for tuberculous abscesses.
  • Viable cell density was identified as the main biological parameter influencing restricted diffusion.

Conclusions:

  • Viable cell density is the primary determinant of restricted diffusion in brain abscesses.
  • The etiological agent does not influence the relationship between cell density and diffusion restriction.
  • DWI can effectively assess cellularity in brain abscesses.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...